Personalized Approach to Selecting Antiplatelet Drugs Improves Outcomes
March 11, 2018
March 11, 2018
ORLANDO, Florida, March 11 -- The American College of Cardiology issued the following news release:
Patients with acute coronary syndrome experienced a substantially lower rate of heart attack, stroke, death from cardiovascular causes and major bleeding at 12 months if genetic information was used to inform the selection of their antiplatelet medication in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
Acute coronary syndrome i . . .
Patients with acute coronary syndrome experienced a substantially lower rate of heart attack, stroke, death from cardiovascular causes and major bleeding at 12 months if genetic information was used to inform the selection of their antiplatelet medication in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
Acute coronary syndrome i . . .